Oliver Pohl

Awards Nomination 20+ Million Readerbase

PMC/PubMed Indexed Articles

Statistical considerations in biosimilar assessment using biosimilarity index

In-vitro Release of Rapamycin from a Thermosensitive Polymer for the Inhibition of Vascular Smooth Muscle Cell Proliferation

Google Scholar citation report

Citations : 4890

Journal of Bioequivalence & Bioavailability received 4890 citations as per Google Scholar report

Journal of Bioequivalence & Bioavailability peer review process verified at publons

25+ Million Website Visitors

Indexed In

Academic Journals Database
Open J Gate
Genamics JournalSeek
Academic Keys
JournalTOCs
China National Knowledge Infrastructure (CNKI)
CiteFactor
Scimago
Ulrich's Periodicals Directory
Electronic Journals Library
RefSeek
Hamdard University
EBSCO A-Z
OCLC- WorldCat
SWB online catalog
Virtual Library of Biology (vifabio)
Publons
MIAR
University Grants Commission
Geneva Foundation for Medical Education and Research
Euro Pub
Google Scholar

Useful Links

Share This Page

Journal Flyer

Journal of Bioequivalence & Bioavailability

Tweets by

Open Access Journals

Oliver Pohl

NCD & Phase I Project Director, Product Development and Manufacturing, PregLem SA, Chemin du Pré-Fleuri 3, CH-1228 Plan-les-Ouates Geneva Switzerland

Biography

Oliver Pohl works in NCD & Phase I Project Director, Product Development and Manufacturing, PregLem SA, Chemin du Pré-Fleuri 3, CH-1228 Plan-les-Ouates Geneva Switzerland.His current research is in Confirmation of the cardiac safety of nolasiban in a randomised cohort of healthy female volunteers